These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 22609107

  • 21. PI3K/AKT pathway activation in bladder carcinogenesis.
    Calderaro J, Rebouissou S, de Koning L, Masmoudi A, Hérault A, Dubois T, Maille P, Soyeux P, Sibony M, de la Taille A, Vordos D, Lebret T, Radvanyi F, Allory Y.
    Int J Cancer; 2014 Apr 15; 134(8):1776-84. PubMed ID: 24122582
    [Abstract] [Full Text] [Related]

  • 22. High thymidylate synthase expression in colorectal cancer with microsatellite instability: implications for chemotherapeutic strategies.
    Ricciardiello L, Ceccarelli C, Angiolini G, Pariali M, Chieco P, Paterini P, Biasco G, Martinelli GN, Roda E, Bazzoli F.
    Clin Cancer Res; 2005 Jun 01; 11(11):4234-40. PubMed ID: 15930362
    [Abstract] [Full Text] [Related]

  • 23. Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis.
    Catasus L, Gallardo A, Cuatrecasas M, Prat J.
    Mod Pathol; 2009 Apr 01; 22(4):522-9. PubMed ID: 19234438
    [Abstract] [Full Text] [Related]

  • 24. MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers.
    Whelan AJ, Babb S, Mutch DG, Rader J, Herzog TJ, Todd C, Ivanovich JL, Goodfellow PJ.
    Int J Cancer; 2002 Jun 10; 99(5):697-704. PubMed ID: 12115503
    [Abstract] [Full Text] [Related]

  • 25. High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma.
    Ishikawa M, Nakayama K, Nakamura K, Ono R, Yamashita H, Ishibashi T, Minamoto T, Iida K, Razia S, Ishikawa N, Kyo S.
    Hum Pathol; 2019 Mar 10; 85():92-100. PubMed ID: 30448219
    [Abstract] [Full Text] [Related]

  • 26. Impact of microsatellite instability (MSI) on survival in high grade endometrial carcinoma.
    Arabi H, Guan H, Kumar S, Cote M, Bandyopadhyay S, Bryant C, Shah J, Abdul-Karim FW, Munkarah AR, Ali-Fehmi R.
    Gynecol Oncol; 2009 May 10; 113(2):153-8. PubMed ID: 19275958
    [Abstract] [Full Text] [Related]

  • 27. Exclusive KRAS mutation in microsatellite-unstable human colorectal carcinomas with sequence alterations in the DNA mismatch repair gene, MLH1.
    Zhao Y, Miyashita K, Ando T, Kakeji Y, Yamanaka T, Taguchi K, Ushijima T, Oda S, Maehara Y.
    Gene; 2008 Nov 01; 423(2):188-93. PubMed ID: 18692554
    [Abstract] [Full Text] [Related]

  • 28. HSP27 expression in primary colorectal cancers is dependent on mutation of KRAS and PI3K/AKT activation status and is independent of TP53.
    Ghosh A, Lai C, McDonald S, Suraweera N, Sengupta N, Propper D, Dorudi S, Silver A.
    Exp Mol Pathol; 2013 Feb 01; 94(1):103-8. PubMed ID: 22982087
    [Abstract] [Full Text] [Related]

  • 29. PI3K pathway dependencies in endometrioid endometrial cancer cell lines.
    Weigelt B, Warne PH, Lambros MB, Reis-Filho JS, Downward J.
    Clin Cancer Res; 2013 Jul 01; 19(13):3533-44. PubMed ID: 23674493
    [Abstract] [Full Text] [Related]

  • 30. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.
    Young J, Simms LA, Biden KG, Wynter C, Whitehall V, Karamatic R, George J, Goldblatt J, Walpole I, Robin SA, Borten MM, Stitz R, Searle J, McKeone D, Fraser L, Purdie DR, Podger K, Price R, Buttenshaw R, Walsh MD, Barker M, Leggett BA, Jass JR.
    Am J Pathol; 2001 Dec 01; 159(6):2107-16. PubMed ID: 11733361
    [Abstract] [Full Text] [Related]

  • 31. Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts.
    Stelloo E, Nout RA, Osse EM, Jürgenliemk-Schulz IJ, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, Nijman HW, Putter H, Bosse T, Creutzberg CL, Smit VT.
    Clin Cancer Res; 2016 Aug 15; 22(16):4215-24. PubMed ID: 27006490
    [Abstract] [Full Text] [Related]

  • 32. Clinical outcomes of patients with microsatellite-unstable colorectal carcinomas depend on L1 methylation level.
    Rhee YY, Kim MJ, Bae JM, Koh JM, Cho NY, Juhnn YS, Kim D, Kang GH.
    Ann Surg Oncol; 2012 Oct 15; 19(11):3441-8. PubMed ID: 22618722
    [Abstract] [Full Text] [Related]

  • 33. Birt-Hogg-Dubé gene mutations in human endometrial carcinomas with microsatellite instability.
    Fujii H, Jiang W, Matsumoto T, Miyai K, Sashara K, Ohtsuji N, Hino O.
    J Pathol; 2006 Jul 15; 209(3):328-35. PubMed ID: 16691634
    [Abstract] [Full Text] [Related]

  • 34. Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: results from studies of the NCIC Clinical Trials Group (NCIC CTG).
    Mackay HJ, Gallinger S, Tsao MS, McLachlin CM, Tu D, Keiser K, Eisenhauer EA, Oza AM.
    Eur J Cancer; 2010 May 15; 46(8):1365-73. PubMed ID: 20304627
    [Abstract] [Full Text] [Related]

  • 35. High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma.
    Garcia-Dios DA, Lambrechts D, Coenegrachts L, Vandenput I, Capoen A, Webb PM, Ferguson K, ANECS, Akslen LA, Claes B, Vergote I, Moerman P, Van Robays J, Marcickiewicz J, Salvesen HB, Spurdle AB, Amant F.
    Gynecol Oncol; 2013 Feb 15; 128(2):327-34. PubMed ID: 23219661
    [Abstract] [Full Text] [Related]

  • 36. Somatic alterations, metabolizing genes and smoking in rectal cancer.
    Curtin K, Samowitz WS, Wolff RK, Herrick J, Caan BJ, Slattery ML.
    Int J Cancer; 2009 Jul 01; 125(1):158-64. PubMed ID: 19358278
    [Abstract] [Full Text] [Related]

  • 37. Unmasking the role of KRAS and BRAF pathways in MSI colorectal tumors.
    Seruca R, Velho S, Oliveira C, Leite M, Matos P, Jordan P.
    Expert Rev Gastroenterol Hepatol; 2009 Feb 01; 3(1):5-9. PubMed ID: 19210107
    [No Abstract] [Full Text] [Related]

  • 38. Sporadic microsatellite instability-high colon cancers rarely display immunohistochemical evidence of Wnt signaling activation.
    Panarelli NC, Vaughn CP, Samowitz WS, Yantiss RK.
    Am J Surg Pathol; 2015 Mar 01; 39(3):313-7. PubMed ID: 25602793
    [Abstract] [Full Text] [Related]

  • 39. Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions.
    Ruemmele P, Dietmaier W, Terracciano L, Tornillo L, Bataille F, Kaiser A, Wuensch PH, Heinmoeller E, Homayounfar K, Luettges J, Kloeppel G, Sessa F, Edmonston TB, Schneider-Stock R, Klinkhammer-Schalke M, Pauer A, Schick S, Hofstaedter F, Baumhoer D, Hartmann A.
    Am J Surg Pathol; 2009 May 01; 33(5):691-704. PubMed ID: 19252434
    [Abstract] [Full Text] [Related]

  • 40. Integrative marker analysis allows risk assessment for metastasis in stage II colon cancer.
    Nitsche U, Rosenberg R, Balmert A, Schuster T, Slotta-Huspenina J, Herrmann P, Bader FG, Friess H, Schlag PM, Stein U, Janssen KP.
    Ann Surg; 2012 Nov 01; 256(5):763-71; discussion 771. PubMed ID: 23095620
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.